Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Physiol ; 239(5): e31249, 2024 May.
Article in English | MEDLINE | ID: mdl-38501376

ABSTRACT

The hippocampal dentate gyrus, responds to diverse pathological stimuli through neurogenesis. This phenomenon, observed following brain injury or neurodegeneration, is postulated to contribute to neuronal repair and functional recovery, thereby presenting an avenue for endogenous neuronal restoration. This study investigated the extent of regenerative response in hippocampal neurogenesis by leveraging the well-established kainic acid-induced status epilepticus model in vivo. In our study, we observed the activation and proliferation of neuronal progenitors or neural stem cell (NSC) and their subsequent migration to the injury sites following the seizure. At the injury sites, new neurons (Tuj1+BrdU+ and NeuN+BrdU+) have been generated indicating regenerative and reparative roles of the progenitor cells. We further detected whether this transient neurogenic burst, which might be a response towards an attempt to repair the brain, is associated with persistent long-term exhaustion of the dentate progenitor cells and impairment of adult neurogenesis marked by downregulation of Ki67, HoPX, and Sox2 with BrdU+ cell in the later part of life. Our studies suggest that the adult brain has the constitutive endogenous regenerative potential for brain repair to restore the damaged neurons, meanwhile, in the long term, it accelerates the depletion of the finite NSC pool in the hippocampal neurogenic niche by changing its proliferative and neurogenic capacity. A thorough understanding of the impact of modulating adult neurogenesis will eventually be required to design novel therapeutics to stimulate or assist brain repair while simultaneously preventing the adverse effects of early robust neurogenesis on the proliferative potential of endogenous neuronal progenitors.


Subject(s)
Hippocampus , Neural Stem Cells , Neurogenesis , Animals , Neural Stem Cells/metabolism , Hippocampus/pathology , Hippocampus/metabolism , Cell Proliferation , Male , Stem Cell Niche , Dentate Gyrus/pathology , Dentate Gyrus/physiopathology , Neurons/metabolism , Neurons/pathology , Kainic Acid/toxicity , Status Epilepticus/chemically induced , Status Epilepticus/pathology , Status Epilepticus/metabolism , Nerve Regeneration , Disease Models, Animal , Mice , Cell Movement
2.
J Med Virol ; 93(3): 1296-1303, 2021 03.
Article in English | MEDLINE | ID: mdl-32964419

ABSTRACT

The recent outbreak of the novel coronavirus, SARS-CoV-2, has emerged to be highly pathogenic in nature. Although lungs are considered as the primary infected organs by SARS-CoV-2, some of the other organs, including the brain, have also been found to be affected. Here, we have discussed how SARS-CoV-2 might infect the brain. The infection of the respiratory center in the brainstem could be hypothesized to be responsible for the respiratory failure in many COVID-19 patients. The virus might gain entry through the olfactory bulb and invade various parts of the brain, including the brainstem. Alternatively, the entry might also occur from peripheral circulation into the central nervous system by compromising the blood-brain barrier. Finally, yet another possible entry route could be its dispersal from the lungs into the vagus nerve via the pulmonary stretch receptors, eventually reaching the brainstem. Therefore, screening neurological symptoms in COVID-19 patients, especially toward the breakdown of the respiratory center in the brainstem, might help us better understand this disease.


Subject(s)
Brain/virology , COVID-19/physiopathology , COVID-19/virology , Neural Pathways/virology , Respiratory Center/virology , SARS-CoV-2/pathogenicity , Animals , Brain/pathology , Brain/physiopathology , COVID-19/pathology , Cytokines/metabolism , Humans , Inflammation , Neural Pathways/physiopathology , Neurons/virology , Respiratory Center/pathology , Respiratory Center/physiopathology , Respiratory Insufficiency , Viral Tropism
3.
Curr Top Med Chem ; 20(13): 1142-1153, 2020.
Article in English | MEDLINE | ID: mdl-32282304

ABSTRACT

BACKGROUND: The central nervous system (CNS) known to regulate the physiological conditions of human body, also itself gets dynamically regulated by both the physiological as well as pathological conditions of the body. These conditions get changed quite often, and often involve changes introduced into the gut microbiota which, as studies are revealing, directly modulate the CNS via a crosstalk. This cross-talk between the gut microbiota and CNS, i.e., the gut-brain axis (GBA), plays a major role in the pathogenesis of many neurodegenerative disorders such as Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and Huntington's disease (HD). OBJECTIVE: We aim to discuss how gut microbiota, through GBA, regulate neurodegenerative disorders such as PD, AD, ALS, MS and HD. METHODS: In this review, we have discussed the present understanding of the role played by the gut microbiota in neurodegenerative disorders and emphasized the probable therapeutic approaches being explored to treat them. RESULTS: In the first part, we introduce the GBA and its relevance, followed by the changes occurring in the GBA during neurodegenerative disorders and then further discuss its role in the pathogenesis of these diseases. Finally, we discuss its applications in possible therapeutics of these diseases and the current research improvements being made to better investigate this interaction. CONCLUSION: We concluded that alterations in the intestinal microbiota modulate various activities that could potentially lead to CNS disorders through interactions via the GBA.


Subject(s)
Brain/physiology , Gastrointestinal Microbiome/physiology , Neurodegenerative Diseases/microbiology , Animals , Brain/drug effects , Brain/pathology , Gastrointestinal Microbiome/drug effects , Humans , Neurodegenerative Diseases/drug therapy , Neurodegenerative Diseases/pathology , Neuroprotective Agents/chemistry , Neuroprotective Agents/pharmacology
4.
ACS Chem Neurosci ; 10(5): 2091-2093, 2019 05 15.
Article in English | MEDLINE | ID: mdl-31007011

ABSTRACT

New neurons were shown to born throughout adulthood, a process known as neurogenesis. Last year, the human hippocampal neurogenesis field was flipped on its head by a paper in Nature from Sorrells et al. questioning the presence of human hippocampal neurogenesis during adulthood ( Sorrells, S.F. et al.  2018 Nature , 555 , 377 - 381 ). Now, a new study by Moreno-Jiménez et al. reported that human brain can make new neurons well beyond middle age until the tenth decade of their life, and earlier studies have failed to find the neurogenesis due to its flawed methods. This paper also finds that production of new neurons drastically drops in patients suffering from Alzheimer's disease. Here, we discuss key findings of this paper, emphasizing how improved protocols and tissue preservation lead to visualization of adult neurogenesis and further highlighting in what way this drop of neurogenesis in Alzheimer's disease brain could possibly open new roads to therapy.


Subject(s)
Alzheimer Disease , Neurogenesis , Adult , Brain , Child , Hippocampus , Humans , Middle Aged , Neurons
SELECTION OF CITATIONS
SEARCH DETAIL